Entero Healthcare Solutions Ltd (NSE:ENTERO)

Q2 2026 Entero Healthcare Solutions Ltd Earnings Call Transcript

Nov 13, 2025 / 09:30 AM GMT

Release Date Price: ₹1147.1 (+1.12%)

Transcript

Key Points

Positve

Entero Healthcare Solutions Ltd (NSE:ENTERO) reported a revenue growth of 20.8% year-on-year and 11.9% quarter-on-quarter, indicating a strong top-line performance.
The company successfully navigated the GST transition, maintaining operational efficiency across its extensive product portfolio.
Entero Healthcare Solutions Ltd (NSE:ENTERO) completed five acquisitions in the med tech segment, significantly expanding its presence and aiming for 1,000 crore plus revenue from acquisitions.
The company achieved a notable improvement in EBITDA margin, reaching 4% in the quarter, driven by higher value categories and operational cost optimization.
Return on capital employed improved to 13.8% from 11.5% in the previous quarter, showcasing enhanced financial efficiency.

Negative

The company faced a delay in closing new inorganic deals, impacting its ability to fully meet its 30% revenue growth guidance for the year.
Operating cash flow was negative in the first half, requiring significant cash generation in the second half to meet the full-year target.
Interest costs increased due to the utilization of funds for acquisitions and milestone payments, impacting net interest expenses.
There was a significant rise in other expenses, partly due to reclassification and expected credit loss provisions.
The company is still working on optimizing its working capital cycle, with a focus on improving inventory management and receivable collections.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ENTE.NS - Entero Healthcare Solutions Ltd
Q2 2026 Entero Healthcare Solutions Ltd Earnings Call
Nov 13, 2025 / 09:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the Q2 and H1F526 earnings conference call of Entero Healthcare Solutions Limited, hosted by Dam Capital Advisors Limited. As a reminder, all the participants' line will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing, then 0 on your touchstone phone. Please note that this conference is being recorded.

Please note this conference call may contain forward-looking statements about the company which are based on the beliefs, opinions, and expectations of the company as of the date of this call. These

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.